TOKYO, Jul 8, 2021 – (JCN Newswire via – Showa Denko (SDK; TSE:4004) announces that, following the “Announcement regarding Company Split (Absorption-Type Company Split) and Transfer of Energy Storage Devices and Systems Business through Share Transfer by a Consolidated Subsidiary (Change of Second-Generation Subsidiary)” which was announced today, SDK […]

TOKYO, Apr 14, 2021 – (JCN Newswire via – Eisai Co., Ltd. announced today that the company will conduct presentations, including the latest data of the investigational anti-amyloid beta (Abeta) protofibril antibody lecanemab (development code: BAN2401), its dual orexin receptor antagonist lemborexant (product name: Dayvigo) and its antiepileptic drug […]